Free Trial

Fortress Biotech (FBIO) Earnings Date, Estimates & Call Transcripts

Fortress Biotech logo
$1.52 -0.05 (-3.18%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$1.54 +0.02 (+1.05%)
As of 04/15/2025 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Fortress Biotech Earnings Summary

Upcoming
Earnings Date
May. 13Before Market OpensEstimated
Consensus EPS
(Mar. 31)
-$0.79
Actual EPS
(Mar. 31)
-$0.26 Beat By $0.53
Actual Revenue
(Mar. 31)
$15.12M

Fortress Biotech announced Q4 2024 earnings on March 31, 2025, reporting an EPS of -$0.26, which topped the consensus estimate of -$0.79 by $0.53. Quarterly revenue was reported to be $15.12 million, below the consensus estimate of $16.30 million. With a trailing EPS of -$2.78, Fortress Biotech's earnings are expected to grow next year, from ($3.28) to ($1.13) per share.

Q4 2024 Earnings Resources

FBIO Upcoming Earnings

Fortress Biotech's next earnings date is estimated for Tuesday, May 13, 2025, based on past reporting schedules.

Get Fortress Biotech Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fortress Biotech and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

FBIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FBIO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

Fortress Biotech Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.44-$0.44-$0.44
Q2 20251-$0.43-$0.43-$0.43
Q3 20251-$0.50-$0.50-$0.50
Q4 20251-$0.28-$0.28-$0.28
FY 20254($1.65)($1.65)($1.65)
Remove Ads

Fortress Biotech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/13/2025
(Estimated)
--------
3/31/2025Q4 2024-$0.79-$0.26+$0.53-$0.26$16.30M$15.12M
8/13/2024--$1.32-$0.73+$0.59-$0.73$14.97M$14.90M
5/15/2024Q1 2024-$2.03-$1.03+$1.00-$1.03$14.33M$13.03M
3/28/2024Q4 2023--$0.53 -$0.53-$0.53$14.46M$19.95M
11/14/2023Q3 2023-$3.53-$0.94+$2.59-$0.94$13.30M$34.75M
8/14/2023Q2 2023-$3.90-$3.60+$0.30-$0.24$13.28M$17.39M
5/15/2023Q1 2023-$2.85-$3.15 -$0.30-$0.21$16.35M$12.43M

Fortress Biotech Earnings - Frequently Asked Questions

Fortress Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on FBIO's earnings history.

In the previous quarter, Fortress Biotech (NASDAQ:FBIO) reported ($0.26) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.79) by $0.53. Learn more on analysts' earnings estimate vs. FBIO's actual earnings.

The conference call transcript for Fortress Biotech's latest earnings report can be read online.
Read Transcript

Fortress Biotech (NASDAQ:FBIO) has a recorded annual revenue of $57.68 million.

Fortress Biotech (NASDAQ:FBIO) has a recorded net income of -$60.64 million. FBIO has generated -$2.78 earnings per share over the last four quarters.

Fortress Biotech's earnings are expected to grow from ($3.28) per share to ($1.13) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:FBIO) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners